Market Place
Sourcing Support
Novartis` Sandoz is recalling 13 drug lots on impurity concerns
25 Mar 2022 //
FIERCEPHARMA
Sandoz Warns Federal Circuit Enbrel Ruling Invites Patent Abuse
04 Aug 2020 //
LAW360
Sandoz Limited, Omeprazole 40 mg Powder for Solution for Infusion, recalled
12 Nov 2019 //
GOV. UK
United illegally blocked generics to Remodulin, Sandoz suit says
18 Apr 2019 //
FIERCE PHARMA
Losartan products under recall - Updated January 22, 2019
23 Jan 2019 //
FDA
A wave of drug recalls hits Indian pharma firms in US
09 Jan 2019 //
DNA INDIA
FDA issues alert, voluntary recall on cardiovascular medication
28 Dec 2018 //
MASSACHUSETTS LIVE
Zhejiang Huahai lambasted in FDA warning for putting profits ahead of safety
12 Dec 2018 //
FIERCE PHARMA
Valsartan products not currently recalled - Updated November 27, 2018
28 Nov 2018 //
FDA
Pfizer responds to FDA, EMA and Canada after plant reinspections
21 Aug 2018 //
FIERCE PHARMA
Tainted valsartan has been on the market for 4 years, FDA discovers
09 Aug 2018 //
FIERCE PHARMA
Valsartan products not currently recalled - Updated August 8, 2018
09 Aug 2018 //
FDA
Valsartan recall: 4 things patients should know
20 Jul 2018 //
CNN
Authorised products containing valsartan as active substance: Overview
16 Jul 2018 //
SWISSMEDIC
Recall of valsartan containing drugs due to contamination with carcinogen
09 Jul 2018 //
HEALTH CANADA
EMA’s CHMP Rejects Two Drugs Approved by US FDA in 2017
24 Mar 2018 //
RAPS
DSM Sinochem licenses enzymatic antibiotic production tech Sandoz- sues Weiqida
16 Mar 2017 //
IN PHARMATECHNOLOGIST
Pfizer hit with US FDA warning at Kansas generic Copaxone site
21 Feb 2017 //
IN PHARMATECHNOLOGIST
Momenta Pharmaceuticals Announces FDA Warning Letter to Contracted Glatopa
18 Feb 2017 //
GLOBENEWSWIRE
Canada seeks Warnings on Prescription Painkillers Amid Rising Deaths
24 Jan 2017 //
REUTERS
Granules India Dips 10% on 11 Observations from Portugal Authority
10 Jan 2017 //
BUSINESS STANDARD
Second for Sandoz, third for US as FDA approves Enbrel biosimilar
31 Aug 2016 //
IN PHARMATECHNOLIGIST
Amgen Asks SC to Reject Challenge to Ruling that Notice of Commercial Marketing
30 Mar 2016 //
FDA LAW BLOG
Amgen files Declaratory Judgment Action against Sandoz over NEULASTA® Biosimilar
08 Mar 2016 //
PATENT DOCS
The FDA offers a controversial solution to the biosimilars name game
29 Aug 2015 //
FIERCE BIOTECH
FDA proposes adding suffixes to distinguish biosimilar drug names
27 Aug 2015 //
REUTERS
Amgen v. Sandoz (Fed. Cir. 2015)
20 Jul 2015 //
PATENT DOCS
Amgen v. Sandoz -- Federal Circuit Oral Argument
07 Jun 2015 //
PATENT DOCS
Biosimilars: New guidance from FDA to help manufacturers develop more treatment options
14 May 2015 //
FDA VOICE
InSite Vision Inc. v. Sandoz, Inc.
14 Apr 2015 //
PATENT DOCS
Awesome Baby; We Love This Game! An Update on Pending Hatch-Waxman and BPCIA Litigation
09 Apr 2015 //
FDA LAW BLOG
Amgen Doubles Down On Bid To Block Novartis` Biosimilar Neupogen
26 Mar 2015 //
FIERCE PHARMA
FDA Drug Shortages: Piperacillin and Tazobactam (Zosyn) Injection
25 Mar 2015 //
FDA
FDA Drug Shortages: Cefazolin Injection
25 Mar 2015 //
FDA
Amgen Loses Bid to Block a Biosimilar Version of its Best-Selling Drug
20 Mar 2015 //
PHARMALOT
Novartis Pays $12.6M Fine for Giving Inaccurate Pricing Data to Medicare
17 Mar 2015 //
PHARMALOT
Biosimilars bill Approved by Colorado Legislature
13 Mar 2015 //
DENVER BUSINESS JOURNAL
No Leg to Stand On: Sandoz Takes on Amgen’s Bid for an Injunction in Filgrastim Biosimilar Litigation
28 Feb 2015 //
FDA LAW BLOG
